Found: 50
Select item for more details and to access through your institution.
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
- Published in:
- Prostate, 1986, v. 9, n. 3, p. 247, doi. 10.1002/pros.2990090305
- By:
- Publication type:
- Article
Fluorescent androgen derivatives do not discriminate between androgen receptor-positive and -negative human tumor cell lines.
- Published in:
- Prostate, 1984, v. 5, n. 4, p. 425, doi. 10.1002/pros.2990050407
- By:
- Publication type:
- Article
Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 10, p. 1879, doi. 10.1007/s00432-015-1981-7
- By:
- Publication type:
- Article
High prevalence of codon 213.
- Published in:
- International Journal of Cancer, 1998, v. 76, n. 3, p. 299, doi. 10.1002/(SICI)1097-0215(19980504)76:3<299::AID-IJC2>3.0.CO;2-Q
- By:
- Publication type:
- Article
Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors.
- Published in:
- International Journal of Cancer, 1996, v. 69, n. 6, p. 475, doi. 10.1002/(SICI)1097-0215(19961220)69:6<475::AID-IJC10>3.0.CO;2-0
- By:
- Publication type:
- Article
Prognostic significance of TP53 accumulation in human primary breast cancer: Comparison between a rapid quantitative immunoassay and SSCP analysis.
- Published in:
- International Journal of Cancer, 1996, v. 69, n. 2, p. 125, doi. 10.1002/(SICI)1097-0215(19960422)69:2<125::AID-IJC10>3.0.CO;2-8
- By:
- Publication type:
- Article
Association between rb-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival.
- Published in:
- International Journal of Cancer, 1995, v. 64, n. 2, p. 140, doi. 10.1002/ijc.2910640212
- By:
- Publication type:
- Article
Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: Correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
- Published in:
- International Journal of Cancer, 1994, v. 57, n. 4, p. 468, doi. 10.1002/ijc.2910570405
- By:
- Publication type:
- Article
Receptors for hormones and growth factors and (ONCO)-gene amplification in human ovarian cancer.
- Published in:
- International Journal of Cancer, 1992, v. 52, n. 2, p. 218, doi. 10.1002/ijc.2910520211
- By:
- Publication type:
- Article
Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro.
- Published in:
- International Journal of Cancer, 1992, v. 51, n. 3, p. 439, doi. 10.1002/ijc.2910510317
- By:
- Publication type:
- Article
Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.
- Published in:
- Head & Neck, 2007, v. 29, n. 4, p. 341, doi. 10.1002/hed.20527
- By:
- Publication type:
- Article
Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast.
- Published in:
- Journal of Pathology, 1999, v. 189, n. 2, p. 169, doi. 10.1002/(SICI)1096-9896(199910)189:2<169::AID-PATH408>3.0.CO;2-P
- By:
- Publication type:
- Article
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway.
- Published in:
- Molecular Cancer, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12943-015-0464-4
- By:
- Publication type:
- Article
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women’s Cancers.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0143178
- By:
- Publication type:
- Article
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0103988
- By:
- Publication type:
- Article
Microarray-Based Oncogenic Pathway Profiling in Advanced Serous Papillary Ovarian Carcinoma.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022469
- By:
- Publication type:
- Article
Determination of steroid hormone-dependency of tumours utilizing tissue sections. Survey of histochemical techniques and their application in surgical pathology.
- Published in:
- Journal of Pathology, 1986, v. 149, n. 3, p. 163, doi. 10.1002/path.1711490302
- By:
- Publication type:
- Article
A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 4, p. 1470, doi. 10.1210/jc.2005-2156
- By:
- Publication type:
- Article
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Re: Limits of Predictive Models Using Microarray Data for Breast Cancer Clinical Treatment Outcome.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 24, p. 1851, doi. 10.1093/jnci/dji433
- By:
- Publication type:
- Article
TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 3, p. 415, doi. 10.3390/biom10030415
- By:
- Publication type:
- Article
CHEK2*1100delC homozygosity in the Netherlands-prevalence and risk of breast and lung cancer.
- Published in:
- European Journal of Human Genetics, 2014, v. 22, n. 1, p. 46, doi. 10.1038/ejhg.2013.85
- By:
- Publication type:
- Article
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.
- Published in:
- BMC Genomics, 2008, v. 9, p. 1, doi. 10.1186/1471-2164-9-239
- By:
- Publication type:
- Article
CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 143, n. 1, p. 171, doi. 10.1007/s10549-013-2777-6
- By:
- Publication type:
- Article
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 139, n. 1, p. 39, doi. 10.1007/s10549-013-2529-7
- By:
- Publication type:
- Article
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 3, p. 843, doi. 10.1007/s10549-011-1663-3
- By:
- Publication type:
- Article
Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 116, n. 2, p. 263, doi. 10.1007/s10549-008-0125-z
- By:
- Publication type:
- Article
TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 113, n. 2, p. 253, doi. 10.1007/s10549-008-9934-3
- By:
- Publication type:
- Article
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 113, n. 2, p. 275, doi. 10.1007/s10549-008-9939-y
- By:
- Publication type:
- Article
Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
- Published in:
- Breast Cancer Research & Treatment, 2006, v. 99, n. 1, p. 97, doi. 10.1007/s10549-006-9186-z
- By:
- Publication type:
- Article
Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer.
- Published in:
- Carcinogenesis, 2002, v. 23, n. 2, p. 311, doi. 10.1093/carcin/23.2.311
- By:
- Publication type:
- Article
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2 and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 1, p. 1, doi. 10.1186/bcr3606
- By:
- Publication type:
- Article
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 1, p. 1, doi. 10.1186/bcr3598
- By:
- Publication type:
- Article
In reply to the letter by Gevaert et al.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 6, p. 1512, doi. 10.1002/ijc.21984
- By:
- Publication type:
- Article
Molecular profiling of platinum resistant ovarian cancer.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 8, p. 1963, doi. 10.1002/ijc.21599
- By:
- Publication type:
- Article
Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients.
- Published in:
- Genes, Chromosomes & Cancer, 1996, v. 16, n. 3, p. 170, doi. 10.1002/(SICI)1098-2264(199607)16:3<170::AID-GCC3>3.0.CO;2-W
- By:
- Publication type:
- Article
Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1591-4
- By:
- Publication type:
- Article
Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13.
- Published in:
- 2015
- By:
- Publication type:
- journal article
TP53 and ovarian cancer.
- Published in:
- Human Mutation, 2003, v. 21, n. 3, p. 285, doi. 10.1002/humu.10181
- By:
- Publication type:
- Article
MicroRNA Regulation of RAD51 in Serous Ovarian Cancer and Chemotherapy Response.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
MicroRNA regulation of RAD51 in serous ovarian cancer modulates chemotherapy response.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validation.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2017, v. 55, n. 9, p. 1291, doi. 10.1515/cclm-2016-0947
- By:
- Publication type:
- Article
LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 8, p. 1363, doi. 10.1016/j.molonc.2016.07.004
- By:
- Publication type:
- Article
Mismatch repair and treatment resistance in ovarian cancer.
- Published in:
- BMC Cancer, 2006, v. 6, p. 201, doi. 10.1186/1471-2407-6-201
- By:
- Publication type:
- Article